How To Get High With No Drugs
Meeting Presentations | Drugs
CDER professionals participate in several meetings, conferences and workshops throughout the year. Appealing primarily to the pharmaceutical industry and health care professionals, topics can range from users fees, to drug advertising and marketing, to genomics, to over-the-counter products. Materials and overviews from some of those meetings are listed in the presentations library.
2021 Presentations
2020 Presentations
| Title | Presenter(s) | Date |
|---|---|---|
| State of CDER 2020 (PDF - 431 KB) | Patrizia Cavazzoni, MD | 10/8/2020 |
2019 Presentations
2018 Presentations
| Title | Presenter(s) | Date |
|---|---|---|
| Search for Balance: FDA's Approach to the Opioids Crisis (PDF - 2 MB) | Douglas C. Throckmorton, MD | 3/9/2019 |
| Federal Efforts to Prevent Drug Shortages An FDA Perspective (PDF - 66 KB) | Douglas C. Throckmorton, MD | 12/27/2018 |
| Charge to the Committee (PDF - 1MB) | Douglas C. Throckmorton, MD | 12/13/2018 |
| Addressing Opioids: The FDA Response to Challenges in Public Health (PDF - 1 MB) | Douglas C. Throckmorton, MD | 12/12/2018 |
| CDER New Drugs Program: 2018 Update (PDF - 977 KB) | Khushboo Sharma, MBA, RAC | 12/11/2018 |
| CDER Office of Surveillance and Epidemiology: 2018 Update (PDF - 2 MB) | Gerald J. Dal Pan, MD, MHS | 12/11/2018 |
| FDA Update on Drug Compounding (PDF - 1 MB) | Julie Dohm, J.D., Ph.D. | 10/04/2018 |
| FDA Center Updates: CDER (PDF - 409 KB) | Douglas C. Throckmorton, M.D. | 9/26/2018 |
| OGD Update: Welcome to much more than GDUFA II (PDF - 847 KB) | Kathleen Uhl, M.D. | 9/7/2018 |
| FDA Update: 2018 (PDF - 975 KB) | Douglas C. Throckmorton, M.D. | 5/21/2018 |
| FDA Update: 2018 (PDF - 1 MB) | Douglas C. Throckmorton, M.D. | 5/17/2018 |
| Update: Biosimilar Program in the U.S. (PDF - 236 KB) | Leah Christl, Ph.D. | 4/27/2018 |
| Biosimilar Regulatory Policy: Understanding the Landscape and Relevance to Medical Practice (PDF - 584 KB) | Sue Lim, M.D. | 4/14/2018 |
| Biosimilar and Interchangeable Products: The U.S. FDA Perspective (PDF - 313 KB) | Joe Franklin, J.D., Ph.D. | 4/14/2018 |
| FDA's Actions to Address the Opioid Epidemic (PDF - 1MB) | Douglas C. Throckmorton, M.D. | 3/14/2018 |
| The Role of Social Science in Prescription Drug Promotion at FDA and Preview of Upcoming Studies (PDF - 282 KB) | Kathryn J. Aikin, Ph.D. | 3/9/2018 |
Back to Top
2017 Presentations
| Title | Presenter(s) | Date |
|---|---|---|
| Center for Drug Evaluation and Research - Compliance Central with FDA Center Compliance Directors: Part 1 (PDF - 810 KB) | Donald D. Ashley, JD | 12/6/2017 |
| CDER Update (PDF - 88 KB) | Janet Woodcock, MD | 12/5/2017 |
| CDER Office of Surveillance and Epidemiology: 2017 Update (PDF - 3.6 MB) | Gerald J. Dal Pan, MD, MHS | 12/5/2017 |
| CDER New Drugs Program: 2017 Update (PDF - 543 KB) | Patrick Frey | 12/5/2017 |
| FDA's Role in Confronting the Opioid Epidemic (PDF - 1 MB) | Douglas C. Throckmorton, M.D. | 11/14/2017 |
| State of OGD: Pivoting to GDUFA II (PDF - 1 MB) | Kathleen Uhl, M.D. | 11/6/2017 |
| FDA's Role in Confronting the Opioid Epidemic (PDF - 823 KB) | Douglas C. Throckmorton, M.D. | 10/12/2017 |
| FDA's Role in Confronting the Opioid Epidemic (PDF - 818 KB) | Douglas C. Throckmorton, M.D. | 9/18/2017 |
| The Collaborative for Effective Prescription Opioids quarterly meeting on September 12, 2017 (PDF - 336 KB) | Douglas C. Throckmorton, M.D. | 9/12/2017 |
| FDA Role in Marijuana Regulation (PDF - 851 KB) | Douglas C. Throckmorton, M.D. | 7/19/2017 |
| Current Expectations and Guidance, Including Data Integrity and Compliance with CGMP (PDF - 796 KB) | Sarah Barkow and Karen Takahashi | 3/30/2017 |
| The Public Health Role of Drug Regulation in the US (PDF - 1 MB) | Douglas C. Throckmorton, M.D. | 3/20/2017 |
| FDA Perspective on Abuse-Deterrent Opioid Development (PDF - 1 MB) | Douglas C. Throckmorton, M.D. | 3/7-8/2017 |
| Bridging Justifications: Supporting the Safety of Excipients in Generic Drug Products (PDF - 495 KB) | Robert T. Dorsam, Ph.D. | 2/27/2017 |
| Compliance Trends (PDF - 725 KB) | Paula Katz | 2/24/2017 |
| Future of Drug Development (PDF - 380 KB) | Janet Woodcock, M.D. | 2/16/2017 |
| CDER 2016 Update for Rare Diseases (PDF - 546 KB) | Richard Moscicki, M.D. | 2/16/2017 |
| FDA Office of Generic Drugs (OGD) Keynote Address, GDUFA: Past, Present and Future (PDF - 475 KB) | Kathleen Uhl, M.D. | 2/14/2017 |
Back to Top
2016 Presentations have been archived. To view them, please see the FDA Archive
2012-2015 Presentations have been archived. To view them, please see the FDA Archive.
Resources For You
- Meetings, Conferences, & Workshops (Drugs)
Back to Top
How To Get High With No Drugs
Source: https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/meeting-presentations-drugs
Posted by: chatmanthavir.blogspot.com
0 Response to "How To Get High With No Drugs"
Post a Comment